MARKET REPORT: Indivior shares dive as it axes schizophrenia drug 0 10.07.2024 00:01 This is money The London-listed pharma company will stop sales of its Perseris medicine because it said the monthly injection is 'no longer financially viable'. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
